inter-alpha-inhibitor

TAPI-0 (TNF alpha processing inhibitor-0)

Carbobenzyloxy-Val-Ala-Asp-alpha-fluoromethylketone

6-O-Acryloyl-1,2:3,4-bis-O-(1-methylethylidene)-alpha-D-galactopyranose contains MEHQ as inhibitor

(+-)-alpha-Cyclohexyl-alpha-phenyl-1-pyrrolidinepropanol hydrochloride

(R)-(-)-ALPHA-METHYLHISTAMINEDIHYDROBROMIDE

Benzeneacetonitrile, alpha-hydroxy-4-(1-methylethyl)-, (alphaR)- (9CI)

4-((Cyclohexylamino)methyl)benzoic acid hydrochloride

1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine

2-Methoxy-6-(pyrazol-1-yl)-benzonitrile

4-(1-Aminobutyl)-2-phenylphenol

1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-

(4-Methyl-tetrahydro-furan-2-yl)-methanol

4-({4-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclohexyl}formamido)-2-methylbutanoic acid

N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide

4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde

tert-Butyl-DL-alanine